A5067048517- Advanced Radiotherapy Techniques
- Breast Cancer Treatment Studies
- Glioma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Lung Cancer Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Neuroblastoma Research and Treatments
- Brain Metastases and Treatment
- Hematopoietic Stem Cell Transplantation
- Radiation Dose and Imaging
- Breast Lesions and Carcinomas
- Endometrial and Cervical Cancer Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Breast Implant and Reconstruction
- Global Cancer Incidence and Screening
- Polyomavirus and related diseases
- Acute Lymphoblastic Leukemia research
- Vascular Tumors and Angiosarcomas
- Brain Tumor Detection and Classification
- Wireless Body Area Networks
- Advances in Oncology and Radiotherapy
- Angiogenesis and VEGF in Cancer
- Advanced MRI Techniques and Applications
Ospedale Policlinico San Martino
2013-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2012-2016
Alleanza Contro il Cancro
2010-2012
National Cancer Research Institute
2012
International School of Trieste
2010
Abstract Purpose This work introduces BreastWatch, a Varian Eclipse script tool designed to help medical physicists, dosimetrists, and radiation oncologists easily inspect improve External Beam Breast Treatment (EBBT) plans using automatic evaluation of protocol dose‐constraints enhanced by Community‐Based approach. Methods BreastWatch examines EBBT Plans Plan Sums, automatically testing the plan's DVH against built‐in international (NRG RTOG1005, ICR Fast‐Forward, FAST, EUROPA 1.2)...
Abstract Background Radiation therapy after lumpectomy is a standard part of breast conserving for invasive carcinoma. The most frequently used schedule worldwide 60 Gy in 30 fractions 6 weeks, time commitment that sporadically may dissuade some otherwise eligible women from undertaking treatment. purpose and primary endpoint this perspective study to evaluate feasibility short-term late toxicity hypofractionated whole irradiation schedule. Methods Between February October 2008 we treated 65...
The use of helical tomotherapy (HT) for craniospinal irradiation (CSI) in pediatric patients remains an issue discussion. In this study, we evaluated the integral dose (ID) to organs at risk (OARs) and whole body delivered with conventional 3-dimensional conformal radiotherapy (3D-CRT) HT made a comparison according different volumes.We selected 10 volumes ages undergoing CSI. Plans 3D-CRT were developed each patient. ID OARs compared statistical analyses performed determine differences.We...
To evaluate once-weekly hypofractionated radiotherapy in elderly patients affected by early breast cancer, reporting acute and late toxicity profiles, treatment feasibility.Fifty were treated with a regimen: 28.5±2.5 Gy five fractions at one fraction weekly. Simultaneous integrated boost (SIB) to the tumor bed high-risk cases.patients over 70 years old, pT1-2, N0-1a. Acute toxicities assessed based on Radiation Therapy Oncology Group.The median follow-up was 20 months patient age 79 years....
We report here the case of a patient with 4 years long-term survival after treatment surgery, chemotherapy, and radiotherapy good local control. This highlights possible role radiation therapy in this tumor.
Background The aim of this study was to evaluate retrospectively the planned dose distribution and acute toxicity adjuvant hypofractionated whole breast radiotherapy (RT) delivered in prone vs. supine position. Methods Twenty-four patients were enrolled; 12 underwent RT with a setup setup. We included according volume (≥500 mL), disease stage (≤pT2/pN1), clinical/biological features. Patients received regimen 35 Gy 10 fractions for 2.5 weeks, concomitant boost 3/4 1 fraction/week. Target...
Aim . To evaluate the toxicity of a hypofractionated schedule for primary radiotherapy (RT) prostate cancer as well value nadir PSA (nPSA) and time to (tnPSA) surrogate efficacy treatment. Material Methods Eighty patients underwent by Helical Tomotherapy (HT). A dose 70.2 Gy was administered in 27 daily fractions 2.6 Gy. Acute late toxicities were graded on RTOG/EORTC scales. The nPSA tnPSA treated with exclusive RT compared an equal cohort 20 conventional fractionation standard conformal...
Second allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment option for patients with acute leukemia who relapse after first HSCT. Although myeloablative conditioning (MAC) regimens before the HSCT are considered superior to reduced- intensity (RIC) in terms of disease control patients, optimal regimen second remains controversial. The most important prognostic factors remission phase at time and an interval >12 months from Total marrow irradiation (TMI) advanced...
The aim of this study is to determine the most beneficial radiation treatment technique for pediatric patients with thoracic and abdominal neuroblastoma (NBL), through a dosimetric comparison between photon Volumetric Modulated Arc Therapy proton Intensity-Modulated Proton plans.